• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?

作者信息

Søreide Kjetil

机构信息

Department of Gastrointestinal Surgery, Hepatopancreatobiliary Unit, Stavanger University Hospital and University of Bergen, Norway.

出版信息

Br J Surg. 2022 Feb 24;109(3):242-243. doi: 10.1093/bjs/znab425.

DOI:10.1093/bjs/znab425
PMID:34875032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364718/
Abstract
摘要

相似文献

1
Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?是时候停止对可切除的结直肠癌肝转移患者进行围手术期化疗了吗？
Br J Surg. 2022 Feb 24;109(3):242-243. doi: 10.1093/bjs/znab425.
2
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?对于可切除肝转移的结直肠癌患者，标准化疗方案是什么？
Nat Clin Pract Oncol. 2009 Jan;6(1):14-6. doi: 10.1038/ncponc1274. Epub 2008 Nov 11.
3
Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.可切除性结直肠癌肝转移术前化疗的试验需要对反应预测因素进行前瞻性评估。
J Clin Oncol. 2008 Aug 1;26(22):3812-3; author reply 3813. doi: 10.1200/JCO.2008.17.8301.
4
Resectable colorectal liver metastases: optimal sequencing of chemotherapy.可切除的结直肠癌肝转移：化疗的最佳顺序
J Gastrointest Cancer. 2012 Sep;43(3):496-8. doi: 10.1007/s12029-011-9272-2.
5
The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?围手术期化疗在可切除性结直肠癌肝转移中的作用：证据支持什么？
J Gastrointest Surg. 2011 Mar;15(3):410-5. doi: 10.1007/s11605-011-1423-z. Epub 2011 Jan 21.
6
Multicentre study of perioperative adjuvant chemotherapy for resectable colorectal liver metastases.多中心研究可切除结直肠癌肝转移的围手术期辅助化疗。
BJS Open. 2019 May 14;3(5):678-686. doi: 10.1002/bjs5.50174. eCollection 2019 Oct.
7
Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer.围手术期二线化疗对结直肠癌辅助化疗期间或早期发生的可切除肝转移灶有益。
Int J Colorectal Dis. 2022 Apr;37(4):805-814. doi: 10.1007/s00384-022-04111-z. Epub 2022 Feb 21.
8
Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.围手术期化疗对因可切除的同步性肝转移而行肝切除术的结直肠癌患者的疗效。
Hepatogastroenterology. 2014 Sep;61(134):1582-7.
9
Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases.对于结直肠癌肝转移肝切除术后辅助化疗的随机试验而言，仅手术的对照臂是必要的，但难以获得。
J Clin Oncol. 2007 Apr 1;25(10):1299-300; author reply 1300. doi: 10.1200/JCO.2006.09.9069.
10
The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis.里程碑系列：随机对照试验研究可切除结直肠癌肝转移的围手术期化疗和术后辅助化疗。
Ann Surg Oncol. 2020 Oct;27(11):4263-4270. doi: 10.1245/s10434-020-08777-z. Epub 2020 Aug 14.

引用本文的文献

1
The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery.结直肠癌肝转移灶消失的挑战：权衡肿瘤生物学与肝脏手术临床后果之间的考量
Clin Exp Metastasis. 2025 Jul 12;42(4):39. doi: 10.1007/s10585-025-10357-y.
2
Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study.新辅助化疗联合贝伐单抗治疗具有复发风险因素的可切除结直肠癌肝转移：一项多中心真实世界研究
Ther Adv Med Oncol. 2025 Mar 26;17:17588359251328457. doi: 10.1177/17588359251328457. eCollection 2025.
3
Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199 analysis.评估贝伐单抗与XELOX方案联合治疗晚期结直肠癌：血清标志物癌胚抗原、糖类抗原125、糖类抗原199分析
World J Clin Cases. 2024 Jan 6;12(1):15-23. doi: 10.12998/wjcc.v12.i1.15.
4
Staged or Simultaneous Surgery for Colon or Rectal Cancer with Synchronous Liver Metastases: Implications for Study Design and Clinical Endpoints.结肠癌或直肠癌伴同时性肝转移的分期手术或同期手术：对研究设计和临床终点的影响
Cancers (Basel). 2023 Apr 6;15(7):2177. doi: 10.3390/cancers15072177.
5
Real-time administration of indocyanine green in combination with computer vision and artificial intelligence for the identification and delineation of colorectal liver metastases.吲哚菁绿与计算机视觉和人工智能相结合用于结直肠癌肝转移灶识别与勾画的实时给药
Surg Open Sci. 2023 Mar 2;12:48-54. doi: 10.1016/j.sopen.2023.03.004. eCollection 2023 Mar.

本文引用的文献

1
Neoadjuvant immunotherapy in primary and metastatic colorectal cancer.新辅助免疫治疗在原发性和转移性结直肠癌中的应用。
Br J Surg. 2021 Dec 1;108(12):1417-1425. doi: 10.1093/bjs/znab342.
2
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.mFOLFOX6方案辅助肝切除与单纯肝切除治疗单纯肝转移结直肠癌的比较（JCOG0603）：一项II期或III期随机对照试验
J Clin Oncol. 2021 Dec 1;39(34):3789-3799. doi: 10.1200/JCO.21.01032. Epub 2021 Sep 14.
3
Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis.结直肠癌肝转移术后化疗疗效的系统评价和荟萃分析。
Eur J Surg Oncol. 2021 Dec;47(12):3113-3122. doi: 10.1016/j.ejso.2021.07.024. Epub 2021 Jul 31.
4
Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.奥沙利铂辅助化疗治疗结直肠癌后长期化疗引起的周围神经病变（CIPN）的系统评价。
Support Care Cancer. 2022 Jan;30(1):33-47. doi: 10.1007/s00520-021-06502-4. Epub 2021 Aug 19.
5
Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.用于预测结直肠肝转移切除术后生存的轮廓预后模型：使用最大直径和 RAS 突变状态的转移瘤数量进行的开发和多中心验证研究。
Br J Surg. 2021 Aug 19;108(8):968-975. doi: 10.1093/bjs/znab086.
6
Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.一线治疗期间结直肠癌肝转移患者集中重复可切除性评估：前瞻性研究。
Br J Surg. 2021 Jul 23;108(7):817-825. doi: 10.1093/bjs/znaa145.
7
Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis.术前门静脉或门静脉和肝静脉栓塞：DRAGON 协作组分析。
Br J Surg. 2021 Jul 23;108(7):834-842. doi: 10.1093/bjs/znaa149.
8
Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.初始不可切除的结直肠癌肝转移患者接受系统化疗和肝动脉化疗后，发生转化切除与生存的相关的独特基因组图谱。
Ann Surg. 2022 Nov 1;276(5):e474-e482. doi: 10.1097/SLA.0000000000004613. Epub 2020 Nov 17.
9
The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis.里程碑系列：随机对照试验研究可切除结直肠癌肝转移的围手术期化疗和术后辅助化疗。
Ann Surg Oncol. 2020 Oct;27(11):4263-4270. doi: 10.1245/s10434-020-08777-z. Epub 2020 Aug 14.
10
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.可切除结直肠肝转移新辅助化疗（EPOC）：含或不含西妥昔单抗的多中心随机对照 3 期临床试验的长期结果。
Lancet Oncol. 2020 Mar;21(3):398-411. doi: 10.1016/S1470-2045(19)30798-3. Epub 2020 Jan 31.